Institut fuer klinische Forschung und Entwicklung Berlin GmbH

Berlin 10437

0 studies enrolling now · 1 studies all time

What they study most

Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early